Valuation: Asia Pacific Silk Road Investment Co Ltd

Market Cap 306M 38.96M 34.26M 32.4M 29.4M 55.21M 3.74B 55.54M 387M 150M 1.91B 146M 143M 6.13B P/E 2024
-3.29x
P/E 2025 -17.7x
Enterprise Value 287M 36.57M 32.16M 30.41M 27.59M 51.82M 3.51B 52.14M 364M 141M 1.79B 137M 134M 5.76B EV / Sales 2024
0.56x
EV / Sales 2025 2.38x
Free-Float
46.65%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 54 17/10/2025
Chief Investment Officer 51 28/02/2022
Corporate Secretary 36 31/05/2023
Director TitleAgeSince
Chairman 54 16/12/2020
Director/Board Member 61 13/08/2021
Director/Board Member 51 31/08/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 38.96M
-1.19%-5.32%-0.01%+25.68% 64.67B
-4.35%-5.29%-40.34%+43.17% 34.46B
-1.07%-5.43%-12.54%+11.90% 29.54B
-2.00%-2.59%+61.62%+158.79% 24.53B
-1.95%-4.69%-4.05%+136.98% 23.73B
-3.92%-6.07%-43.07%+109.61% 21.41B
-2.86%-4.08%-25.47%-3.01% 15.64B
-3.26%-6.62% - - 14.92B
-1.23%-7.81%+4.48%+36.83% 14.79B
Average -1.31%-3.14%-7.42%+64.99% 27.08B
Weighted average by Cap. -1.24%-2.75%-7.00%+58.96%

Financials

2024 2025
Net sales 169M 21.5M 18.9M 17.88M 16.22M 30.46M 2.06B 30.65M 214M 82.6M 1.05B 80.69M 78.95M 3.38B 126M 16.08M 14.14M 13.37M 12.13M 22.78M 1.54B 22.92M 160M 61.77M 788M 60.34M 59.04M 2.53B
Net income -34.73M -4.43M -3.89M -3.68M -3.34M -6.27M -425M -6.31M -44.03M -17.01M -217M -16.62M -16.26M -697M -16.75M -2.14M -1.88M -1.78M -1.61M -3.03M -205M -3.04M -21.24M -8.2M -105M -8.02M -7.84M -336M
Net Debt -28.73M -3.66M -3.22M -3.05M -2.76M -5.19M -351M -5.22M -36.43M -14.07M -179M -13.75M -13.45M -576M -18.73M -2.39M -2.1M -1.99M -1.8M -3.38M -229M -3.4M -23.75M -9.18M -117M -8.96M -8.77M -376M
Logo Asia Pacific Silk Road Investment Co Ltd
Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.
Employees
-